Clinical pearls for the monitoring and treatment of antipsychotic induced metabolic syndrome

Clinical pearls for the monitoring and treatment of antipsychotic induced metabolic syndrome

Antipsychotic medications increase the risk of metabolic syndrome, which then increases the risk of atherosclerotic cardiovascular disease and premature death. Routinely monitoring for signs of metabolic syndrome in patients taking antipsychotics allows for early detection and intervention. Psychiat...

Full description

Bibliographic Details
Main Author: Beth M. DeJongh, PharmD, BCPP, BCPS
Format: Article
Language:English
Published: American Association of Psychiatric Pharmacists 2021-11-01
Series:Mental Health Clinician
Subjects:
antipsychotics
metabolic syndrome
weight
lipids
blood pressure
psychiatric pharmacist
Online Access:https://theijpt.org/doi/pdf/10.9740/mhc.2021.11.311

Similar Items

Similar Items